Cellectis S.A. Cash and Cash Equivalents 2011-2026 | CLLS

Annual Cash and Cash Equivalents Cellectis S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
143 M	137 M	89.8 M	186 M	241 M	341 M	452 M	256 M	255 M	342 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
452 M	89.8 M	244 M

Quarterly Cash and Cash Equivalents Cellectis S.A.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	186 M	-	248 M	-	241 M	-	261 M	-	341 M	-	397 M	-	452 M	-	-	-	256 M	-	-	-	255 M	-	-	-	342 M	-	-	-	136 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
452 M	136 M	283 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	345 K	-	-10.17 %	$ 12.2 K	USA
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Autolus Therapeutics plc AUTL	240 M	$ 1.95	-2.5 %	$ 498 M	Britain
AlloVir ALVR	118 M	-	4.14 %	$ 49.1 M	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	172 M	$ 11.7	21.57 %	$ 757 M	USA
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	89.4 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
Ascendis Pharma A/S ASND	560 M	$ 212.12	1.35 %	$ 5 B	Danmark
Aclaris Therapeutics ACRS	24.6 M	$ 2.69	1.51 %	$ 208 M	USA
AIkido Pharma AIKI	4.08 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	13.4 M	-	-	$ 2.17 B	USA
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	144 M	-	-15.15 %	$ 60.3 M	Britain
Athersys ATHX	37.4 M	-	3.77 %	$ 22.4 M	USA
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 4.72	18.59 %	$ 10.3 B	Israel
BioNTech SE BNTX	9.76 B	$ 101.08	3.05 %	$ 27.2 B	Germany
Amphastar Pharmaceuticals AMPH	152 M	$ 27.36	-0.96 %	$ 1.33 B	USA
Avenue Therapeutics ATXI	2.59 M	-	-52.27 %	$ 4.45 M	USA
AVROBIO AVRO	98 M	-	1083.1 %	$ 745 M	USA
CASI Pharmaceuticals CASI	38.7 M	$ 0.83	-2.51 %	$ 113 M	USA
BioDelivery Sciences International BDSI	112 M	-	-4.8 %	$ 255 M	USA
Catalyst Biosciences CBIO	33.5 M	$ 10.99	-0.72 %	$ 723 M	USA
Arena Pharmaceuticals ARNA	220 M	-	-6.81 %	$ 3.04 B	USA
BeiGene, Ltd. BGNE	2.63 B	-	0.49 %	$ 251 B	Cayman-islands
Acer Therapeutics ACER	2.33 M	-	2.71 %	$ 14 M	USA
BioVie BIVI	17.5 M	$ 1.38	-1.03 %	$ 2.04 M	USA
Axon Enterprise AXON	455 M	$ 619.64	-1.12 %	$ 46.9 B	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	31 M	$ 2.84	4.41 %	$ 17.8 M	USA
AstraZeneca PLC AZN	5.49 B	$ 94.45	-0.54 %	$ 96.9 B	Britain
Bellicum Pharmaceuticals BLCM	21.8 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	86.5 M	-	-7.31 %	$ 87 M	USA
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	10.9 M	-	-5.38 %	$ 6.06 M	USA
Burford Capital Limited BUR	322 M	$ 9.32	0.27 %	$ 1.51 B	Britain
bluebird bio BLUE	222 M	-	-	$ 546 M	USA
Biogen BIIB	2.38 B	$ 184.21	0.87 %	$ 26.8 B	USA
Cellectar Biosciences CLRB	9.56 M	$ 3.24	0.62 %	$ 39.6 M	USA
Abeona Therapeutics ABEO	14.5 M	$ 5.19	0.58 %	$ 111 M	USA
Corcept Therapeutics Incorporated CORT	128 M	$ 37.18	3.91 %	$ 3.84 B	USA
ADiTx Therapeutics ADTX	833 K	$ 0.86	-2.54 %	$ 11.3 K	USA